氨丙啉盐酸盐 [用于生化研究]
|
A129501-5g
|
≥98% |
137-88-2 |
5g
|
¥ 35.9
|
现货 |
阿拉丁 |
AZD1981,CRTh2 (DP2) 拮抗剂
|
A129498-25mg
|
Moligand™, ≥98% |
802904-66-1 |
25mg
|
¥ 1968.9
|
现货 |
阿拉丁 |
AZD1981,CRTh2 (DP2) 拮抗剂
|
A129498-5mg
|
Moligand™, ≥98% |
802904-66-1 |
5mg
|
¥ 448.9
|
现货 |
阿拉丁 |
AZ 960
|
A129464-10mg
|
Moligand™, ≥98% |
905586-69-8 |
10mg
|
¥ 2199.9
|
现货 |
阿拉丁 |
AZ 960
|
A129464-5mg
|
Moligand™, ≥98% |
905586-69-8 |
5mg
|
¥ 1399.9
|
现货 |
阿拉丁 |
AZ 960
|
A129464-2mg
|
Moligand™, ≥98% |
905586-69-8 |
2mg
|
¥ 699.9
|
现货 |
阿拉丁 |
阿米舒必利
|
A129432-1g
|
Moligand™, ≥98% |
71675-85-9 |
1g
|
¥ 234.9
|
现货 |
阿拉丁 |
阿米舒必利
|
A129432-250mg
|
Moligand™, ≥98% |
71675-85-9 |
250mg
|
¥ 154.9
|
现货 |
阿拉丁 |
阿米舒必利
|
A129432-50mg
|
Moligand™, ≥98% |
71675-85-9 |
50mg
|
¥ 82.9
|
现货 |
阿拉丁 |
阿西美辛
|
A129429-25g
|
≥98% |
53164-05-9 |
25g
|
¥ 138.9
|
现货 |
阿拉丁 |
阿西美辛
|
A129429-5g
|
≥98% |
53164-05-9 |
5g
|
¥ 60.9
|
现货 |
阿拉丁 |
阿西美辛
|
A129429-1g
|
≥98% |
53164-05-9 |
1g
|
¥ 28.9
|
现货 |
阿拉丁 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯酰胺对甲苯磺酸盐
|
A129426-50mg
|
≥98% |
1050500-29-2 |
50mg
|
¥ 4633.9
|
期货,请咨询 |
阿拉丁 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯酰胺对甲苯磺酸盐
|
A129426-10mg
|
≥98% |
1050500-29-2 |
10mg
|
¥ 1472.9
|
期货,请咨询 |
阿拉丁 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯酰胺对甲苯磺酸盐
|
A129426-5mg
|
≥98% |
1050500-29-2 |
5mg
|
¥ 893.9
|
期货,请咨询 |
阿拉丁 |
硫酸阿米卡星
|
A129422-25g
|
≥97% |
39831-55-5 |
25g
|
¥ 240.9
|
现货 |
阿拉丁 |
硫酸阿米卡星
|
A129422-5g
|
≥97% |
39831-55-5 |
5g
|
¥ 92.9
|
现货 |
阿拉丁 |
硫酸阿米卡星
|
A129422-1g
|
≥97% |
39831-55-5 |
1g
|
¥ 49.9
|
现货 |
阿拉丁 |
4-(p-甲苯基硫)噻吩并[2,3-c]吡啶-2-甲酰胺
|
A129416-50mg
|
≥98% |
251992-66-2 |
50mg
|
¥ 670.9
|
现货 |
阿拉丁 |
4-(p-甲苯基硫)噻吩并[2,3-c]吡啶-2-甲酰胺
|
A129416-10mg
|
≥98% |
251992-66-2 |
10mg
|
¥ 222.9
|
现货 |
阿拉丁 |
阿洛西林钠盐
|
A129398-25g
|
≥99% |
37091-65-9 |
25g
|
¥ 2129.9
|
现货 |
阿拉丁 |
阿洛西林钠盐
|
A129398-5g
|
≥99% |
37091-65-9 |
5g
|
¥ 488.9
|
现货 |
阿拉丁 |
盐酸阿替卡因
|
A129389-1g
|
≥99% |
23964-57-0 |
1g
|
¥ 60.9
|
现货 |
阿拉丁 |
盐酸阿替卡因
|
A129389-250mg
|
≥99% |
23964-57-0 |
250mg
|
¥ 39.9
|
现货 |
阿拉丁 |